TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 49.8B
Net Income 1.7B 3.50%
EPS (Diluted) $7.72

Balance Sheet Metrics

Total Assets 119.7B
Total Liabilities 77.1B
Shareholders Equity 42.6B
Debt to Equity 1.81

Cash Flow Metrics

Operating Cash Flow -294.0M
Free Cash Flow 821.0M

Revenue & Profitability Trend

Elevance Health Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i176.8B171.3B156.6B138.6B121.9B
Cost of Goods Sold i-----
Gross Profit i-----
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i--17.7B15.9B17.4B
Other Operating Expenses i39.8B37.4B30.7B26.8B9.0B
Total Operating Expenses i39.8B37.4B48.4B42.7B26.4B
Operating Income i-----
Operating Margin % i0.0%0.0%0.0%0.0%0.0%
Non-Operating Items
Interest Income i-----
Interest Expense i1.2B1.0B851.0M798.0M784.0M
Other Non-Operating Income22.6B19.5B15.0B12.7B10.4B
Pre-tax Income i7.9B7.7B7.6B8.0B6.2B
Income Tax i1.9B1.7B1.7B1.8B1.7B
Effective Tax Rate % i24.5%22.3%22.5%23.1%26.7%
Net Income i6.0B6.0B5.9B6.1B4.6B
Net Margin % i3.4%3.5%3.8%4.4%3.8%
Key Metrics
EBITDA i-----
EPS (Basic) i$25.81$25.69$25.32$25.25$18.63
EPS (Diluted) i$25.68$25.22$24.81$24.73$17.98
Basic Shares Outstanding i231700000233071088237958067241770746245401430
Diluted Shares Outstanding i231700000233071088237958067241770746245401430

Income Statement Trend

Elevance Health Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i8.3B6.5B7.4B4.9B5.7B
Short-term Investments i25.2B29.6B26.0B26.3B23.4B
Accounts Receivable i8.0B7.9B7.1B5.7B5.3B
Inventory i-----
Other Current Assets-----
Total Current Assets i-----
Non-Current Assets
Property, Plant & Equipment i-----
Goodwill i68.6B60.9B59.1B59.1B52.8B
Intangible Assets i12.1B10.3B10.3B10.6B9.4B
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i-----
Total Assets i116.9B----
Liabilities
Current Liabilities
Accounts Payable i22.7B23.0B21.2B18.5B16.9B
Short-term Debt i2.0B1.9B1.8B1.9B700.0M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i-----
Non-Current Liabilities
Long-term Debt i29.2B23.2B22.3B21.2B19.3B
Deferred Tax Liabilities i2.1B2.0B2.0B2.8B2.0B
Other Non-Current Liabilities-----
Total Non-Current Liabilities i-----
Total Liabilities i75.5B----
Equity
Common Stock i2.0M2.0M2.0M2.0M3.0M
Retained Earnings i33.5B31.7B29.6B27.1B23.8B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i41.4B39.4B36.3B36.1B33.2B
Key Metrics
Total Debt i31.2B25.1B24.1B23.0B20.0B
Working Capital i00000

Balance Sheet Composition

Elevance Health Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i6.0B6.0B5.9B6.1B4.6B
Depreciation & Amortization i-----
Stock-Based Compensation i191.0M289.0M264.0M255.0M283.0M
Working Capital Changes i121.0M-682.0M-2.0B-1.4B1.7B
Operating Cash Flow i5.9B5.0B4.0B5.3B6.0B
Investing Activities
Capital Expenditures i-1.3B-1.3B-1.2B-1.1B-1.0B
Acquisitions i-4.4B-1.6B-649.0M-3.5B-2.0B
Investment Purchases i-18.0B-16.2B-24.9B-18.7B-19.5B
Investment Sales i18.6B13.5B22.6B14.6B16.1B
Investing Cash Flow i-5.2B-5.6B-4.6B-9.6B-7.3B
Financing Activities
Share Repurchases i-2.9B-2.7B-2.3B-1.9B-2.7B
Dividends Paid i-1.5B-1.4B-1.2B-1.1B-954.0M
Debt Issuance i7.7B2.6B3.1B3.5B2.5B
Debt Repayment i-2.4B-2.2B-3.6B-2.5B-3.8B
Financing Cash Flow i274.0M-3.7B-3.5B-2.2B-5.3B
Free Cash Flow i4.6B6.8B7.2B7.3B9.7B
Net Change in Cash i1.0B-4.3B-4.0B-6.5B-6.5B

Cash Flow Trend

Elevance Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 13.14
Forward P/E 8.86
Price to Book 1.59
Price to Sales 0.37
PEG Ratio -0.60

Profitability Ratios

Profit Margin 2.83%
Operating Margin 5.29%
Return on Equity 12.42%
Return on Assets 4.65%

Financial Health

Current Ratio 1.44
Debt to Equity 68.84
Beta 0.59

Per Share Data

EPS (TTM) $23.56
Book Value per Share $194.46
Revenue per Share $828.61

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
elv69.7B13.141.5912.42%2.83%68.84
UnitedHealth 244.5B11.692.5821.65%5.04%75.58
CVS Health 87.0B19.111.125.88%1.18%106.67
Cigna 79.2B16.281.9713.18%1.92%76.10
Humana 33.9B21.591.869.03%1.28%70.63
Centene 14.0B6.920.517.44%1.29%63.91

Financial data is updated regularly. All figures are in the company's reporting currency.